Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Regulus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGLS.
You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.
Other companies in Regulus Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), Voyager Therapeutics (NASDAQ:VYGR), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharmaceuticals (NASDAQ:ELDN).
Regulus Therapeutics has a consensus price target of $7.14.
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $7.9 last updated April 30, 2025 at 2:34 PM EDT.
There are no upcoming dividends for Regulus Therapeutics.
Regulus Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Regulus Therapeutics.
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.